Methotrexate infusion and folinic acid in the primary therapy of nonmetastatic gestational trophoblastic tumors
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 36 (1) , 56-59
- https://doi.org/10.1016/0090-8258(90)90108-w
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexateAmerican Journal of Obstetrics and Gynecology, 1987
- Single agent weekly methotrexate (MTX) therapy in the treatment of nonmetastatic gestational trophoblastic disease (NMGTD)Gynecologic Oncology, 1987
- Ten years' experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic diseaseGynecologic Oncology, 1986
- Methotrexate with citrovorum factor rescue in gestational trophoblastic diseaseAmerican Journal of Obstetrics and Gynecology, 1985
- Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasmsAmerican Journal of Obstetrics and Gynecology, 1984
- Single-dose actinomycin D in the treatment of postmolar trophoblastic diseaseGynecologic Oncology, 1984
- Pelvic ultrasonography and the management of gestational trophoblastic diseaseGynecologic Oncology, 1983
- Pretreatment curettage—A predictor of chemotherapy response in gestational trophoblastic neoplasiaGynecologic Oncology, 1980
- INFUSION THERAPY FOR PELVIC TROPHOBLASTIC TUMOURSBJOG: An International Journal of Obstetrics and Gynaecology, 1964
- Effect of Methotrexate Therapy upon Choriocarcinoma and ChorioadenomaExperimental Biology and Medicine, 1956